Trastuzumab Emtansine Market Analysis by Application (Breast Cancer), by Type (60mg, 100mg, 150mg, 160mg, Others), and by distribution channel (Hospitals, Clinics, speciality care centers Others) and by Region: Global Forecast, 2024 - 2034
- PUBLISHED ON
- 2024-04-24
- NO OF PAGES
- 231
- CATEGORY
- Healthcare & Life Sciences
Market Overview
The Trastuzumab Emtansine market is predicted to develop at a compound annual growth rate (CAGR) of xx% from 2024 to 2034, when it is projected to reach USD xx Million, based on an average growth pattern. The market is estimated to reach a value of USD xx Million in 2024.
SOURCE: We Market Research
Kadcyla, also
known as trastuzumab emtansine, is a targeted treatment for breast cancer that
is HER2-positive. It combines two drugs: emtansine, a chemotherapeutic medication,
and trastuzumab, which inhibits HER2 protein signaling. Emtansine damages the
microtubule network of cancer cells, causing them to die, while trastuzumab
binds to the HER2 receptors on those cells. By concentrating on cancer cells,
this combination reduces harm to healthy tissue. When other therapies have
failed and breast cancer has progressed or returned, it is frequently utilized.
Transtuzumab emtansine can improve treatment efficacy and minimize adverse
effects by delivering chemotherapy straight to cancer cells, giving patients
with advanced HER2-positive breast cancer hope.
The growing
prevalence of HER2-positive breast cancer, improvements in cancer treatment
that favor targeted therapies, and the drug's shown ability to improve patient
outcomes are some of the factors driving the market for trastuzumab emtansine
(T-DM1). Other important factors include raising awareness, improving access to
healthcare, and continuing research and development. Together, these elements
propel the demand for trastuzumab emtansine, a targeted and efficient therapy
option that gives patients with HER2-positive breast cancer hope and shapes the
market's growth trajectory.
Market Scope
|
Report Attributes |
Description |
|
Market Size in 2024 |
USD xx Million |
|
Market Forecast in 2034 |
USD xx Million |
|
CAGR % 2024-2034 |
xx% |
|
Base Year |
2023 |
|
Historic Data |
2016-2022 |
|
Forecast Period |
2024-2034 |
|
Report USP Â |
Production, Consumption, company share, company
heatmap, company production capacity, growth factors and more |
|
Segments Covered |
by Application, by Type, by distribution channel and By Region |
|
Regional Scope |
North America, Europe, APAC, South America and
Middle East and Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic
Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia;
Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa;
Nigeria |
Â
Trastuzumab Emtansine Industry: Dynamics & Restrains
Â
We Market Research: Trastuzumab Emtansine Dashboard
Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.
Trastuzumab Emtansine Segmentation
Market- By Application Analysis
By Application, the Trastuzumab Emtansine
Market is Categories into Breast Cancer. The Breast Cancer segment accounts for
the largest share.
For HER2-positive breast cancer,
trastuzumab emtansine is a beneficial treatment choice because it provides
targeted therapy that targets cancer cells directly while causing the least
amount of harm to healthy cells. Its application has enhanced the prognosis and
quality of life for HER2-positive breast cancer patients, underscoring the need
of tailored strategies in cancer care.
The
following segments are part of an in-depth analysis of the global Trastuzumab
Emtansine market:
|
Market Segments |
 |
|
By Type |
·       Â
60mg ·       Â
100mg ·       Â
150mg ·       Â
160mg ·       Â
Others |
|
By distribution channel |
·       Â
Hospitals ·       Â
Clinics ·       Â
speciality care centers ·       Â
Others |
Â
Trastuzumab Emtansine Industry: Regional Analysis
North America Market Forecast
North America dominate the Trastuzumab Emtansine Market with the highest revenue generating market with share of more than 46%. The Trastuzumab Emtansine market in North America thrives due to the Advanced healthcare infrastructure, coupled with a high prevalence of breast cancer and substantial research investments, position the region as a leader in Trastuzumab Emtansine adoption and development.
Europe Market Statistics
Europe is the
second largest region in Trastuzumab Emtansine market due to the demand for
Trastuzumab Emtansine is driven in European countries by a combination of
strong healthcare systems, advantageous reimbursement regulations, and
increasing awareness efforts.
 Asia Pacific Market Forecasts
Asia Pacific is
expected to be the fastest-growing regional segment of the Trastuzumab
Emtansine market during the forecast period. In the Asia Pacific region, Trastuzumab
Emtansine has a major market opportunity in the area due to rapidly increasing
healthcare investments and a burgeoning patient population seeking
sophisticated cancer medicines.
Key Market Players
The Trastuzumab Emtansine Market is dominated by a few
large companies, such as
·       Â
Amgen
·       Â
Pfizer
·       Â
Genentech
·       Â
Accord Healthcare
·       Â
Nippon Kayaku
·       Â
Chugai Pharmaceutical
·       Â
Daiichi Sankyo
·       Â
Samsung Bioepis
·       Â
Mylan(Viatris)
·        Celltrion
·         Other
1.    Â
Global
Trastuzumab Emtansine Market Introduction and Market Overview
1.1.   Objectives of the Study
1.2.   Global Trastuzumab Emtansine
Market Scope and Market Estimation
1.2.1. Global Trastuzumab Emtansine Overall
Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)
1.2.2. Global Trastuzumab Emtansine
Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034
1.3.   Market Segmentation
1.3.1. Component of Global Trastuzumab
Emtansine Market
1.3.2. Technology of Global Trastuzumab
Emtansine Market
1.3.3. Distribution channel  of Global Trastuzumab Emtansine Market
1.3.4. Region of Global Trastuzumab
Emtansine Market
2.    Â
Executive Summary
2.1.   Global Trastuzumab Emtansine Market Industry Trends under COVID-19
Outbreak
2.1.1. Global COVID-19 Status Overview
2.1.2. Influence of COVID-19 Outbreak
on Global Trastuzumab Emtansine Market
Industry Development
2.2.   Market Dynamics
2.2.1. Drivers
2.2.2. Limitations
2.2.3. Opportunities
2.2.4. Impact Analysis of Drivers and
Restraints
2.3.   Pricing Trends Analysis &
Average Selling Prices (ASPs)
2.4.   Key Mergers & Acquisitions,
Expansions, JVs, Funding / VCs, etc.
2.5.   Porter’s Five Forces Analysis
2.5.1. Bargaining Power of Suppliers
2.5.2. Bargaining Power of Buyers
2.5.3. Threat of Substitutes
2.5.4. Threat of New Entrants
2.5.5. Competitive Rivalry
2.6.   Value Chain / Ecosystem Analysis
2.7.   Russia-Ukraine War Impacts
Analysis
2.8.   Economic Downturn Analysis
2.9.     Market Investment Opportunity
Analysis (Top Investment Pockets), By Segments & By Region
3.    Â
Global Trastuzumab Emtansine
Market Estimates & Historical Trend
Analysis (2019 - 2023)
4.    Â
Global Trastuzumab Emtansine
Market Estimates & Forecast Trend
Analysis, by TYPE
4.1.   Global Trastuzumab Emtansine
Market Revenue (US$ Mn) Estimates and Forecasts, by TYPE, 2019 to 2034
4.1.1. 60mg
4.1.2. 100mg
4.1.3. 150mg
4.1.4. 160mg
4.1.5. Others
5.    Â
Global Trastuzumab Emtansine
Market Estimates & Forecast Trend
Analysis, by Application
5.1.   Global Trastuzumab Emtansine
Market Revenue (US$ Mn) Estimates and Forecasts, by Application, 2019 to 2034
5.1.1. Breast Cancer
6.    Â
Global Trastuzumab Emtansine
Market Estimates & Forecast Trend
Analysis, by Distribution
channel
6.1.   Global Trastuzumab Emtansine
Market Revenue (US$ Mn) Estimates and Forecasts, by Distribution channel ,
2019 to 2034
6.1.1. Hospitals
6.1.2. Clinics
6.1.3. speciality care centers
6.1.4. Others
7.    Â
Global Trastuzumab Emtansine
Market Estimates & Forecast Trend Analysis,
by Region
7.1.   Global Trastuzumab Emtansine
Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034
7.1.1. North America
7.1.2. Europe
7.1.3. Asia Pacific
7.1.4. Middle East & Africa
7.1.5. South America
8.    Â
North
America Trastuzumab Emtansine Market: Estimates & Forecast Trend Analysis
8.1.  Â
North
America Trastuzumab Emtansine Market Assessments & Key Findings
8.1.1. North America Trastuzumab
Emtansine Market Introduction
8.1.2. North America Trastuzumab
Emtansine Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
8.1.2.1.  By TYPE
8.1.2.2.  By Application
8.1.2.3.  By Distribution
channel
8.1.2.4.  By Country
8.1.2.4.1.    The U.S.
8.1.2.4.2.    Canada
8.1.2.4.3.    Mexico
9.    Â
Europe
Trastuzumab Emtansine Market: Estimates & Forecast Trend Analysis
9.1.   Europe Trastuzumab Emtansine
Market Assessments & Key Findings
9.1.1. Europe Trastuzumab Emtansine
Market Introduction
9.1.2. Europe Trastuzumab Emtansine
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
9.1.2.1.  By TYPE
9.1.2.2.  By Application
9.1.2.3.  By Distribution
channel
9.1.2.4.      Â
By
Country
9.1.2.4.1.    Germany
9.1.2.4.2.    U.K.
9.1.2.4.3.    France
9.1.2.4.4.    Italy
9.1.2.4.5.    Spain
9.1.2.4.6.    Russia
9.1.2.4.7.    Rest of Europe
10. Asia Pacific Trastuzumab
Emtansine Market: Estimates &
Forecast Trend Analysis
10.1. Asia Pacific Market Assessments
& Key Findings
10.1.1.  Asia Pacific Trastuzumab
Emtansine Market Introduction
10.1.2.  Asia Pacific Trastuzumab
Emtansine Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
10.1.2.1.   By TYPE
10.1.2.2.   By Application
10.1.2.3.   By Distribution
channel
10.1.2.4.   By Country
10.1.2.4.1. China
10.1.2.4.2. Japan
10.1.2.4.3. India
10.1.2.4.4. Australia
10.1.2.4.5. South Korea
10.1.2.4.6. ASEAN
10.1.2.4.7. Rest of Asia Pacific
11. Middle East & Africa Trastuzumab
Emtansine Market: Estimates &
Forecast Trend Analysis
11.1. Middle East & Africa Market
Assessments & Key Findings
11.1.1.  Middle
East & Africa Trastuzumab
Emtansine Market Introduction
11.1.2.  Middle
East & Africa Trastuzumab
Emtansine Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
11.1.2.1.   By TYPE
11.1.2.2.   By Application
11.1.2.3.   By Distribution
channel
11.1.2.4.   By Country
11.1.2.4.1. U.A.E.
11.1.2.4.2. Saudi Arabia
11.1.2.4.3. Egypt
11.1.2.4.4. South Africa
11.1.2.4.5. Rest of Middle East & Africa
12. South America
Trastuzumab Emtansine Market: Estimates
& Forecast Trend Analysis
12.1. South America Market Assessments
& Key Findings
12.1.1.  South America Trastuzumab
Emtansine Market Introduction
12.1.2.  South America Trastuzumab
Emtansine Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
12.1.2.1.   By TYPE
12.1.2.2.   By Application
12.1.2.3.   By Distribution
channel
12.1.2.4.   By Country
12.1.2.4.1. Brazil
12.1.2.4.2. Argentina
12.1.2.4.3. Colombia
12.1.2.4.4. Rest of South America
13. Competition Landscape
13.1. Global Trastuzumab Emtansine
Market Competition Matrix & Benchmarking, by Leading Players / Innovators /
Emerging Players / New Entrants
13.2. Global Trastuzumab Emtansine
Market Competition White Space Analysis, By Distribution channel
13.3. Global Trastuzumab Emtansine
Market Competition Heat Map Analysis, By Distribution channel
13.4. Global Trastuzumab Emtansine
Market Concentration & Company Market Shares (%) Analysis, 2022
14. Company Profiles
14.1.                   Â
Amgen.
14.1.1.  Company Overview & Key Stats
14.1.2.  Financial Performance & KPIs
14.1.3.  Product Portfolio
14.1.4.  Business Strategy & Recent
Developments
* Similar details would be provided
for all the players mentioned belowÂ
14.2.     Pfizer
14.3.     Genentech
14.4.     Accord
Healthcare
14.5.     Nippon Kayaku
14.6.     Chugai
Pharmaceutical
14.7.     Daiichi Sankyo
14.8.     Samsung
Bioepis
14.9.     Mylan(Viatris)
14.10. Celltrion
14.11. Others
15. Research
Methodology
15.1. External Transportations /
Databases
15.2. Internal Proprietary Database
15.3. Primary Research
15.4. Secondary Research
15.5. Assumptions
15.6. Limitations
15.7. Report FAQs
16. Research Findings & Conclusion
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Frequently Asked Questions
What is the market size of Trastuzumab Emtansine Market in 2024?
Trastuzumab Emtansine Market was valued at USD xx Million in 2024.
What is the growth rate for the Trastuzumab Emtansine Market?
Trastuzumab Emtansine Market size will increase at approximate CAGR of xx% during the forecasted period.
Which are the top companies operating within the market?
Major companies operating within the Trastuzumab Emtansine Market Are Amgen, Pfizer, Genentech, Accord Healthcare, Nippon Kayaku, Chugai Pharmaceutical, Daiichi Sankyo, Samsung Bioepis, Mylan(Viatris), Celltrion and Other.
Which region dominates the Trastuzumab Emtansine Market?
North America dominates the market with an active share of 46%.
}})
Select a license type that suits your business needs
US $3750
Only Three Thousand Seven Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4750
Only Four Thousand Seven Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5750
Only Five Thousand Seven Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI